Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Yingjun Chang"'
Autor:
Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiaodong Mo
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-6 (2024)
Externí odkaz:
https://doaj.org/article/5a7c6e2fb0144401a74c63ef619aa443
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 2, Pp 140-151 (2024)
Abstract. Chimeric antigen receptor (CAR)-modified T-cell therapy has achieved remarkable success in the treatment of acute lymphoblastic leukemia (ALL). Measurable/minimal residual disease (MRD) monitoring plays a significant role in the prognostica
Externí odkaz:
https://doaj.org/article/953c564568b84a0585f46b072829b93b
Autor:
Jing Liu, Depei Wu, Qifa Liu, Yingjun Chang, Yang Xu, Fen Huang, Xiaojun Huang, Yu Wang, Lishao Guo
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 15, Pp 1855-1863 (2023)
Background:. Although the need for consolidation chemotherapy after successful induction therapy is well established in patients with acute myeloid leukemia (AML) in first complete remission (CR1), the value of consolidation chemotherapy before allog
Externí odkaz:
https://doaj.org/article/aed0b082738946ca81e39319aeacd13c
Autor:
Xiangyu Zhao, Haotian Wu, Yifei Cheng, Zhengli Xu, Yuhong Chen, Yingjun Chang, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaojun Huang, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 16, Pp 2011-2013 (2023)
Externí odkaz:
https://doaj.org/article/3a98ed9cbe75471b95e439fe7ebff745
Autor:
Mingyue Zhao, Yalan Zhou, Hao Jiang, Leiming Cao, Lixin Wu, Lixia Liu, Jiayue Qin, Shanbo Cao, Yingjun Chang, Qian Jiang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Guorui Ruan
Publikováno v:
HemaSphere, Vol 7, p e25232da (2023)
Externí odkaz:
https://doaj.org/article/918fd8b017714818b96278095ac708d1
Autor:
Weijia Zhao, Yujia Wang, Xinwei Zhang, Jie Hao, Kunshan Zhang, Xiaojun Huang, Yingjun Chang, Hounan Wu, Rong Jin, Qing Ge
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionEarly recovery of donor-derived invariant natural killer T (iNKT) cells are associated with reduced risk of graft-versus-host disease (GvHD) and overall survival. Patients with severe GvHD, however, had much slower iNKT cell reconstitutio
Externí odkaz:
https://doaj.org/article/0f3fc6c8fbe74b78989691cfaff1c22d
Autor:
Xuan Cai, Haixia Fu, Xiangyu Zhao, Jin Lu, Qian Jiang, Yingjun Chang, Xiaojun Huang, Xiaohui Zhang, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 19, Pp 2344-2350 (2022)
Background:. Recombinant human thrombopoietin (rh-TPO) and eltrombopag are two distinct TPO receptor agonists (TPO-RAs) with different mechanisms. During the pandemic, when immunosuppressive medications are controversial, switching to another TPO-RA
Externí odkaz:
https://doaj.org/article/aeb5c41b5bdc4753b9e7ffc2783cfc8c
Autor:
Guoju You, Man Zhang, Zhilei Bian, Huidong Guo, Zhengyang Xu, Yanli Ni, Yu Lan, Wen Yue, Yandong Gong, Yingjun Chang, Xiaojun Huang, Bing Liu
Publikováno v:
Cell Discovery, Vol 8, Iss 1, Pp 1-15 (2022)
Abstract Granulocyte colony-stimulating factor (G-CSF) has been widely used to mobilize bone marrow hematopoietic stem/progenitor cells for transplantation in the treatment of hematological malignancies for decades. Additionally, G-CSF is also accept
Externí odkaz:
https://doaj.org/article/ef3095779cb3436e97ccc3f0db8c09f9
Autor:
Guanhua Hu, Yifei Cheng, Yingxi Zuo, Yingjun Chang, Pan Suo, Yueping Jia, Aidong Lu, Yu Wang, Shunchang Jiao, Longji Zhang, Yuqian Sun, Chenhua Yan, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Leping Zhang, Xiaojun Huang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Measurable residual disease (MRD) positivity before haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is an independent prognostic factor in determining outcomes in patients with B-cell acute lymphoblastic leukemia (ALL). In this st
Externí odkaz:
https://doaj.org/article/a2af3c1c69eb468d95c1fee20d05f89d
Autor:
Yanan Wang, Jiamin Zhang, Yan Su, Chencong Wang, Gaochao Zhang, Xiao Liu, Qi Chen, Meng Lv, Yingjun Chang, Jun Peng, Ming Hou, Xiaojun Huang, Xiaohui Zhang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 20, Iss , Pp 764-776 (2020)
Immune thrombocytopenia (ITP) is a common hematological autoimmune disease, in which defective mesenchymal stem cells (MSCs) are potentially involved. Our previous study suggested that MSCs in ITP patients displayed enhanced apoptosis. MicroRNAs (miR
Externí odkaz:
https://doaj.org/article/a70d8c22f79d4d3e9f7c7fec0390e8d7